Navigation Links
Anesiva Announces Expansion of Zingo Agreement in Europe
Date:5/1/2008

SOUTH SAN FRANCISCO, Calif., May 1 /PRNewswire-FirstCall/ -- Anesiva, Inc. (Nasdaq: ANSV) today announced the expansion of the company's license and distribution agreement for Zingo(TM) with Sigma-Tau SpA to include additional European countries. Zingo (lidocaine hydrochloride monohydrate) powder intradermal injection system is approved in the United States to provide topical local analgesia prior to peripheral IV insertions or blood draws in children three to 18 years of age.

Under the expanded agreement, Sigma-Tau now has exclusive rights to market and distribute Zingo in all major European markets, excluding the British Isles and the Scandinavian countries. Terms of the expanded agreement include additional upfront payments to Anesiva and transfer price, as well as a milestone payment.

"The expansion of this agreement reflects enthusiasm about the global potential for Zingo to provide quick-onset, needle-free analgesia prior to peripheral venous access procedures in children," said Samantha R. Miller, Anesiva's vice president, business development. "Since the initial agreement was signed in February 2008, Sigma-Tau has made significant progress in defining the regulatory pathway to support commercialization of Zingo in the licensed countries."

About Zingo(TM)

Zingo(TM) is an easy-to-administer, single-use, needle-free system that delivers sterile lidocaine powder to provide topical, local anesthesia to reduce the pain associated with peripheral IV insertions or blood draws. Zingo's rapid onset of action allows intravenous line placement or venipuncture to begin one to three minutes after administration. Zingo is approved in the U.S. to reduce the pain associated with peripheral IV insertions or blood draws i
'/>"/>

SOURCE Anesiva, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Anesiva Announces New Zingo Marketing and Distribution Agreement
2. Anesiva Announces Submission of Supplemental New Drug Application for Zingo(TM) to Reduce Pain Associated With Needle Insertion Procedures in Adults
3. Anesiva Announces March 5, 2008 Presentation at Susquehanna Financial Group Healthcare Conference
4. Anesiva Announces Fourth Quarter and Year-End 2007 Financial Results and Provides 2008 Outlook
5. Anesiva Appoints Daniel Janney to Board of Directors
6. Anesiva Announces Fourth Quarter and Year End 2007 Financial Results Conference Call and February 2008 Conference Participation
7. Anesiva Announces Completion of Common Stock Offering
8. Anesiva Raises $45 Million in Common Stock Offering
9. Anesiva Outlines Comprehensive Commercialization Plan for FDA Approved Product Zingo(TM)
10. Anesiva Signs Co-Promotion and Distribution Agreement With Sagent Pharmaceuticals for Zingo(TM) in U.S. Hospitals
11. Anesiva to Present at BioCenturys NewsMakers in the Biotech Industry Conference on September 6, 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/14/2014)... CAMBRIDGE, Mass. , July 14, 2014 ... in the development of new therapies to treat neuropsychiatric ... Ahlholm has been appointed vice president of finance ... Mr. Ahlholm is a senior executive with more ... functions at technology and life science companies. His background ...
(Date:7/12/2014)... York (PRWEB) July 12, 2014 ... for various reagents used in the life ... driving the life science reagents market towards ... include manufacturers and providers of life science ... Market Report: http://www.transparencymarketresearch.com/life-sciences-reagents-analytical-reagents.html . , The ...
(Date:7/11/2014)... BCC Research ( http://www.bccresearch.com ) reveals ... REACTION (PCR) TECHNOLOGY: GLOBAL MARKETS , the global market ... $140 billion in 2013. This is estimated to grow ... annual growth rate (CAGR) of 28.6%. , New digital ... exciting possibilities within the broader PCR field. The opportunities ...
(Date:7/11/2014)... 2014 Cayenne Medical, Inc., a ... the soft tissue reconstruction segment, announced the worldwide ... surgeries involving the shoulder and extremities. The SureLock ... inserter-controlled deployment method. The unique delivery eliminates manual ... pull-out, or anchor displacement (also commonly know as ...
Breaking Biology Technology:Minerva Neurosciences Announces Appointment Of Frederick W. Ahlholm As VP Of Finance And Chief Accounting Officer 2Transparency Market Research: Life Science Reagents Market- PCR Reagent Kits, Cell and Tissue Culture, Flow Cytometry, Electrophoresis and Chromatography 2Transparency Market Research: Life Science Reagents Market- PCR Reagent Kits, Cell and Tissue Culture, Flow Cytometry, Electrophoresis and Chromatography 3Global Market for Digital Polymerase Chain Reaction Technology to Reach $490 Billion by 2018; Equipment Sector Accounts for the Fastest Growing Segment With 33% CAGR 2Global Market for Digital Polymerase Chain Reaction Technology to Reach $490 Billion by 2018; Equipment Sector Accounts for the Fastest Growing Segment With 33% CAGR 3Cayenne Medical Launches SureLock™ All-Suture Anchor System for Shoulder and Extremity Surgery 2Cayenne Medical Launches SureLock™ All-Suture Anchor System for Shoulder and Extremity Surgery 3
... scientists will be presenting their latest research findings at ... in Otolaryngology (ARO). ,When: February 25-29, 2012 ... Diego, California, USA Additional Information: Research topics ... Bilateral ≠ Binaural: Can the Ability to Localize ...
... of the figures scientists create are stunning. Others are not ... fall somewhere in between. A deluge of data presents a ... that can crowd out the figure,s main message. A group ... matching students in science and those in design. The new ...
... the 21st century owes a tremendous amount to advances ... the flow of electrical charges using increasingly small and ... race ahead, researchers at the University of Pennsylvania are ... electricity with light. "Looking at the success of ...
Cached Biology Technology:NIH-funded science on hearing research at annual ARO meeting 2NIH-funded science on hearing research at annual ARO meeting 3NIH-funded science on hearing research at annual ARO meeting 4NIH-funded science on hearing research at annual ARO meeting 5NIH-funded science on hearing research at annual ARO meeting 6Design eye for the science guy: Drop-in clinic helps scientists communicate data 2Design eye for the science guy: Drop-in clinic helps scientists communicate data 3Penn researchers build first physical 'metatronic' circuit 2Penn researchers build first physical 'metatronic' circuit 3Penn researchers build first physical 'metatronic' circuit 4
(Date:7/11/2014)... July 11, 2014 Researchers have pioneered ... images. The new technology, called Virtual Finger, allows ... structures like neurons and synapses using the flat ... technology makes 3D imaging studies orders of magnitude ... an unprecedented level across many areas of experimental ...
(Date:7/11/2014)... transplantation of mesenchymal stem cells can stimulate neurogenesis in ... Alzheimer,s disease (AD) and improve tissue and function injury ... reported on the therapeutic effect of adipose-derived stem cells ... effect on oxidative injury and neurogenesis in the brain ... School of Life Sciences, Tsinghua University, China transplanted ADSCs ...
(Date:7/11/2014)... normal circumstances, astrocytes participate in normal physiological ... exhibit therapeutic and repairing effects on brain ... found that nerve cells differentiated from adipose-derived ... viability, which produces influences on subsequent studies ... Hospital, Hebei United University, China demonstrated that ...
Breaking Biology News(10 mins):Virtual finger enables scientists to navigate and analyze complex 3D images 2
... time that exercise induces neurogenesis in a specific brain ... mechanism was not fully understood. The hippocampus plays an ... one of the brain regions where new neurons are ... maturation , The researchers demonstrated that mice with ...
... turtles are benefiting from marine protected areas by using habitats ... study that is the first to track the federally protected ... listed as endangered in Florida and threatened throughout the rest ... after their forays to nest on beaches in the Southeast ...
... PHILADELPHIAA new study looking at the genomes of more ... with an increased risk of testicular cancer, the most ... from this first-of-its-kind meta-analysis were reported online May 12 ... Perelman School of Medicine at the University of ...
Cached Biology News:Serotonin mediates exercise-induced generation of new neurons 2Sea turtles benefiting from protected areas 2Sea turtles benefiting from protected areas 3Penn Medicine researchers identify 4 new genetic risk factors for testicular cancer 2Penn Medicine researchers identify 4 new genetic risk factors for testicular cancer 3
Direct ELISA Assay Diluent - EDTA, 10 L...
... Immunogen: Synthetic peptide derived from ... junctophilin-3. Specificity: Specific for the ... Reactivity: Mouse (positive controls: mouse ... heart tissues). Applications: Western blotting ...
... agarose gel electrophoresis into an automated, high-throughput ... bufferless, pre-cast system is ideal for analyzing ... and more. Fully automated, robot-compatible, and ready ... system makes your high-throughput screening assignments as ...
...
Biology Products: